Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tubular function in multiple myeloma.

R A Coward, N P Mallick, I W Delamore

    Clinical Nephrology
    |October 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    In myeloma patients, light chain proteinuria is linked to kidney damage. The study identifies specific nephrotoxic light chains and sensitive markers for tubular injury and dysfunction, aiding in understanding renal impairment.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Development of pilonidal sinus in an old exit site four years after removal of the Tenckhoff catheter.

    Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2010
    Same author

    Hepatitis C and holiday dialysis. A postal survey of UK renal units.

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2000
    Same author

    Timing of sildenafil therapy in dialysis patients-lessons following an episode of hypotension.

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2000
    Same author

    Determination of copper and zinc in blood plasma by ion chromatography using a cobalt internal standard.

    The Analyst·1999
    Same author

    Peritoneal dialysis.

    Lancet (London, England)·1999
    Same author

    Haemodialysis.

    Lancet (London, England)·1999
    Same journal

    Clinical characteristics and outcomes of adults with minimal change disease: A retrospective, cross-sectional study.

    Clinical nephrology·2026
    Same journal

    Analysis of end-stage renal disease mediated by cuproptosis-related genes.

    Clinical nephrology·2026
    Same journal

    The relationship between red cell distribution width and platelet ratio in acute kidney injury among ventilator-associated pneumonia patients: A MIMIC-IV database study.

    Clinical nephrology·2026
    Same journal

    Arterial stiffness and choroidal vascularity index in autosomal dominant polycystic kidney disease with preserved kidney function.

    Clinical nephrology·2026
    Same journal

    Antibody-drug conjugate therapy in a renal transplant patient with bladder cancer: A case report.

    Clinical nephrology·2026
    Same journal

    Epigenetic age enhances eGFR-based prediction of all-cause mortality: A cross-cohort validation of a novel risk model.

    Clinical nephrology·2026
    See all related articles

    Area of Science:

    • Nephrology
    • Oncology
    • Biochemistry

    Background:

    • Light chain proteinuria is associated with renal damage in multiple myeloma.
    • The specific nephrotoxic potential of different light chains requires further elucidation.
    • Early detection of tubular injury and dysfunction is crucial for managing myeloma-related kidney disease.

    Purpose of the Study:

    • To confirm the association between light chain proteinuria and renal damage in myeloma patients.
    • To investigate the role of the amount and type of excreted light chains in nephrotoxicity.
    • To identify sensitive markers for tubular injury and dysfunction in myeloma-associated kidney disease.

    Main Methods:

    • Analysis of light chain excretion and renal function markers in 42 myeloma patients.

    Related Experiment Videos

  • Measurement of N-acetyl-beta-D-glucosaminidase (NAG) as an index of proximal tubular injury.
  • Assessment of low molecular weight proteinuria (Retinol Binding Protein, Lysozyme) for tubular dysfunction.
  • Evaluation of distal tubular function (acid load, concentrating ability) and association with specific conditions.

    • Main Results:

    • Confirmed association between light chain proteinuria and renal damage.
    • Identified specific light chains as potentially nephrotoxic, beyond mere quantity.
    • N-acetyl-beta-D-glucosaminidase excretion was a sensitive marker of tubular injury.
    • Low molecular weight proteinuria indicated tubular dysfunction in kidneys with impaired Glomerular Filtration Rate (GFR).
    • Isolated distal tubular defects were rare, usually part of global impairment or specific conditions like hyperviscosity or crystal deposition.
    • Hypercalcemia specifically impaired concentrating ability, independent of acidification defects.

    Conclusions:

    • The type of light chain, not just the amount, is critical for nephrotoxicity in myeloma.
    • Urinary N-acetyl-beta-D-glucosaminidase and low molecular weight proteins are valuable biomarkers for myeloma-related kidney injury.
    • Distal tubular dysfunction is uncommon in isolation and often linked to specific myeloma complications.
    • Hypercalcemia has a distinct impact on renal concentrating ability.